Brent is an experienced life science consultant who utilizes his background in clinical science and business to provide clients with actionable insights and strategies to confront their most pressing challenges. He possesses a strong background in market access and reimbursement strategy across the pharmaceutical, diagnostic, and device industries. His experience spans all settings of care and multiple therapeutic areas, including oncology, GI, neurology, and rare disease.
During his career, Brent has supported numerous clients from initial strategy through execution. His prior engagements range from coding and coverage analyses, to reengineering DRGs for novel high cost inpatient products. He brings extensive experience in leading primary research efforts with key stakeholders such as, payer medical directors, physicians, and hospital administrators through telephone depth interviews and advisory boards. Prior to joining Blue Fin Group, Brent was a Senior Consultant at Navigant Consulting Inc.